Swissmedic approves Xadago® (safinamide) for use in Parkinson’s Disease 4 December 2015 Zambon S.p.A., an International Pharmaceutical Company with a strong commitment in central nervous system (CNS) diseases, and its partner Newron Pharmaceuticals S.p.A
Linkedin